ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Novo Nordisk A/s Complete list of announcements declared & dividend announcements by Novo Nordisk A/s NVO

Novo Nordisk A/s NVO listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Novo Nordisk A/s NVO

: Novo Nordisk partners with Valo Health on AI drug discovery
Novo Nordisk NVO on Monday announced a partnership with Valo Health Inc., a technology company specializing in AI-powered drug discovery and development, to focus on new cardiometabolic drug programs. The Danish pharmaceutical giant, maker of Ozempic and W
Announcement as on 25 September 2023

Beat the Market Like Zacks: Elementis, Novo Nordisk, Amgen in Focus
All three widely followed indexes closed a losing week last Friday. The Dow Jones Industrial Average, the S&P 500 and the Nasdaq Composite declined 1.9%, 2.9% and 3.6%, respectively. For the S&P 500 and Nasdaq, it was the
Announcement as on 25 September 2023

Where Will Novo Nordisk Stock Be in 5 Years?
Novo Nordisk (NYSE: NVO) has been growing in popularity as a result of two incredibly popular drugs, Ozempic and Wegovy. Because of the company's phenomenal growth, it has been a top buy for many investors. But the business is still growing and Novo Nordis
Announcement as on 22 September 2023

Novo Nordisk Is Already Working on Ozempic 2.0. Here's How to Profit
Up 41% so far this year on hot sales of its drug Ozempic, Novo Nordisk (NYSE: NVO) isn't wasting any time in teeing up a few attempts at minting its next blockbuster. Ozempic 2.0 is already in the works, and there's no chance that it'll give up if there's
Announcement as on 07 September 2023

Novo Nordisk is Europe's most valuable firm after launching obesity drug
The company's share price closed up 0.7 per cent to DKK 1,311 (0), giving the company a market capitalisation of 8 billion
Announcement as on 05 September 2023

Announcements by Novo Nordisk A/s first page | Next page | Prev page |

NVO Novo Nordisk A/s current price & indicator signals

Moving Averages for Novo Nordisk A/s

  • 5Day Average: 37.7
  • 12Day Average: 38.77
  • 20Day Average: 40.65
  • 50Day Average: 44.46
  • 100Day Average: 45.41
  • 150Day Average: 43.57
  • 200Day Average: 45.65

NVO Indicators & signals

Indicator MACD (12,26,9)

38.97, 41.13, -1.98
Indicator MACD is in negative zone

Indicator ADX (14)

50, 13.79, 41.38
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 47
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NVO Novo Nordisk A/s are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
05 Mon Oct 2026 37.56 36.46 to 37.76 0.64% 0.64 times
02 Fri Oct 2026 37.32 37.17 to 37.65 -0.24% 0.61 times
01 Thu Oct 2026 37.41 37.37 to 38.15 -1.32% 0.55 times
30 Wed Sep 2026 37.91 37.89 to 38.77 -1.04% 1.28 times
29 Tue Sep 2026 38.31 38.05 to 38.38 -1.03% 0.56 times
28 Mon Sep 2026 38.71 38.23 to 38.90 -0.21% 0.68 times
25 Fri Sep 2026 38.79 38.41 to 38.88 0.41% 0.45 times
24 Thu Sep 2026 38.63 37.61 to 38.72 1.21% 0.87 times
23 Wed Sep 2026 38.17 38.16 to 39.14 -3.12% 1.1 times
22 Tue Sep 2026 39.40 39.11 to 39.89 -1.05% 1.45 times
21 Mon Sep 2026 39.82 39.54 to 43.72 -7.91% 2.44 times
18 Fri Sep 2026 43.24 42.78 to 43.54 0.12% 0.62 times

Videos related to: NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

 

Back to top